Biblio

Export 3166 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
A. Ankur Balmik and Chinnathambi, S., “Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1481-1493, 2018.
M. Bamji-Mirza, Li, Y., Najem, D., Liu, Q. Yan, Walker, D., Lue, L. - F., Stupak, J., Chan, K., Li, J., Ghani, M., Yang, Z., Rogaeva, E., and Zhang, W., “Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 875-92, 2016.
G. Banerjee, Jang, H., Kim, H. Jin, Kim, S. Tae, Kim, J. Seung, Lee, J. Hong, Im, K., Kwon, H., Lee, J. Min, Na, D. L., Seo, S. Won, and Werring, D. John, “Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1485-1497, 2018.
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
K. J. Bangen, Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., and Delano-Wood, L., “Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.”, J Alzheimers Dis, vol. 52, no. 3, pp. 849-61, 2016.
K. J. Bangen, Thomas, K. R., Sanchez, D. L., Edmonds, E. C., Weigand, A. J., Delano-Wood, L., and Bondi, M. W., “Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
K. J. Bangen, Himali, J. J., Beiser, A. S., Nation, D. A., Libon, D. J., Fox, C. S., Seshadri, S., Wolf, P. A., McKee, A. C., Au, R., and Delano-Wood, L., “Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1553-62, 2016.
S. J. Banks, Zhuang, X., Bayram, E., Bird, C., Cordes, D., Caldwell, J. Z. K., and Cummings, J. L., “Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1223-1234, 2018.
W. A. Banks, Kovac, A., Majerova, P., Bullock, K. M., Shi, M., and Zhang, J., “Tau Proteins Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 55, no. 1, pp. 411-419, 2017.
J. Bao, Liang, Z., Gong, X., Yu, J., Xiao, Y., Liu, W., Wang, X., Wang, J. - Z., and Shu, X., “High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.”, J Alzheimers Dis, vol. 85, no. 2, pp. 863-876, 2021.
A. A. Diaz Baquero, Franco-Martín, M. A., Vidales, E. Parra, Toribio-Guzmán, J. Miguel, Bueno-Aguado, Y., Abad, F. Martínez, Bartolomé, M. V. Perea, Asl, A. Mahmoudi, and van der Roest, H. G., “The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
H. Baradaran, Peloso, G. M., Polak, J. F., Killiany, R. J., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A., Romero, J. R., and Seshadri, S., “Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden.”, J Alzheimers Dis, vol. 89, no. 1, pp. 223-232, 2022.
T. M. Baran and Lin, F. Vankee, “Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.”, J Alzheimers Dis, vol. 66, no. 1, pp. 307-318, 2018.
B. J. Baranowski, Hayward, G. C., Fajardo, V. A., and MacPherson, R. E. K., “Increased Prevalence of Obesity/Type 2 Diabetes and Lower Levels of Lithium in Rural Texas Counties May Explain Greater Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 64, no. 1, pp. 303-308, 2018.
M. Barbera, Mangialasche, F., Jongstra, S., Guillemont, J., Ngandu, T., Beishuizen, C., Coley, N., Brayne, C., Andrieu, S., Richard, E., Soininen, H., and Kivipelto, M., “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
C. K. Barha, Hsiung, G. - Y. R., Best, J. R., Davis, J. C., Eng, J. J., Jacova, C., Lee, P. E., Munkacsy, M., Cheung, W., and Liu-Ambrose, T., “Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1397-1410, 2017.
J. Barnes, Bartlett, J. W., Wolk, D. A., van der Flier, W. M., and Frost, C., “Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 631-642, 2018.
F. Barocco, Spallazzi, M., Concari, L., Gardini, S., Pelosi, A., and Caffarra, P., “The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.”, J Alzheimers Dis, vol. 57, no. 3, pp. 775-786, 2017.
L. García Barrado, Coart, E., Vanderstichele, H. M. J., and Burzykowski, T., “Transferring cut-off values between assays for cerebrospinal fluid Alzheimer's disease biomarkers.”, J Alzheimers Dis, vol. 49, no. 1, pp. 187-99, 2016.
H. E. Barry, Cooper, J. A., Ryan, C., A Passmore, P., A Robinson, L., Molloy, G. J., Darcy, C. M., Buchanan, H., and Hughes, C. M., “Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1503-13, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., “Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
N. R. Barthélemy, Toth, B., Manser, P. T., Sanabria-Bohórquez, S., Teng, E., Keeley, M., Bateman, R. J., Weimer, R. M., and Wildsmith, K. R., “Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.”, J Alzheimers Dis, vol. 85, no. 1, pp. 415-429, 2021.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., “Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
N. Bartolotti, Disouky, A., Kalinski, A., Elmann, A., and Lazarov, O., “Phytochemicals from Achillea fragrantissima are Modulators of AβPP Metabolism.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1425-1435, 2018.

Pages